- Home
- BMRA vs ACXP Comparison
BMRA vs ACXP Comparison
Compare BMRA & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- ACXP
- Stock Information
- Founded
- BMRA 1971
- ACXP 2017
- Country
- BMRA United States
- ACXP United States
- Employees
- BMRA N/A
- ACXP N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- ACXP Health Care
- Exchange
- BMRA Nasdaq
- ACXP Nasdaq
- Market Cap
- BMRA 8.2M
- ACXP 6.8M
- IPO Year
- BMRA N/A
- ACXP 2021
- Fundamental
- Price
- BMRA $2.96
- ACXP $6.32
- Analyst Decision
- BMRA
- ACXP Strong Buy
- Analyst Count
- BMRA 0
- ACXP 3
- Target Price
- BMRA N/A
- ACXP $143.67
- AVG Volume (30 Days)
- BMRA 250.1K
- ACXP 1.6M
- Earning Date
- BMRA 10-14-2025
- ACXP 11-12-2025
- Dividend Yield
- BMRA N/A
- ACXP N/A
- EPS Growth
- BMRA N/A
- ACXP N/A
- EPS
- BMRA N/A
- ACXP N/A
- Revenue
- BMRA $4,884,000.00
- ACXP N/A
- Revenue This Year
- BMRA N/A
- ACXP N/A
- Revenue Next Year
- BMRA N/A
- ACXP N/A
- P/E Ratio
- BMRA N/A
- ACXP N/A
- Revenue Growth
- BMRA N/A
- ACXP N/A
- 52 Week Low
- BMRA $2.08
- ACXP $3.80
- 52 Week High
- BMRA $10.16
- ACXP $39.20
- Technical
- Relative Strength Index (RSI)
- BMRA 50.63
- ACXP 54.71
- Support Level
- BMRA $2.82
- ACXP $6.24
- Resistance Level
- BMRA $3.19
- ACXP $6.80
- Average True Range (ATR)
- BMRA 0.20
- ACXP 0.69
- MACD
- BMRA 0.02
- ACXP -0.11
- Stochastic Oscillator
- BMRA 56.53
- ACXP 4.29
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.